6-fluoro-3-tyrosine has been researched along with Parkinson Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendlin, BB; Buyan-Dent, L; Christian, BT; DeJesus, OT; Gallagher, CL; Harding, SJ; Holden, JE; Li, CT; Nickles, RJ; Oh, J; Okonkwo, O; Palotti, M; Stone, CK | 1 |
Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A | 1 |
Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Wahl, L | 1 |
Chen, JJ; Chirakal, R; Nahmias, C; Thompson, M; Wahl, LM | 1 |
4 other study(ies) available for 6-fluoro-3-tyrosine and Parkinson Disease
Article | Year |
---|---|
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tyrosine | 2014 |
Comparative assessment of 6-[
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine | 2017 |
A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain.
Topics: Adolescent; Adult; Aromatic-L-Amino-Acid Decarboxylases; Blood-Brain Barrier; Brain; Carbidopa; Corpus Striatum; Dopamine; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Parkinson Disease; Radionuclide Imaging; Reference Values; Tyrosine | 1995 |
The time course of metabolites in human plasma after 6-[(18)F]fluoro-l-m-tyrosine administration.
Topics: Antiparkinson Agents; Brain; Carbidopa; Dopamine; Fluorine Radioisotopes; Humans; Parkinson Disease; Time Factors; Tomography, Emission-Computed; Tyrosine | 1999 |